Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heinz Feldmann

Showing results (61-70 of 495) with videos related to

Pageof 50
Sort By:
Plos Pathogens|September 16, 2021
The Ebola virus soluble glycoprotein contributes to viral pathogenesis by activating the MAP kinase signaling pathwayWakako Furuyama, Kyle Shifflett, Heinz Feldmann, et al.
Microorganisms|April 30, 2021
Lassa Virus Treatment OptionsFrederick Hansen, Michael A Jarvis, Heinz Feldmann, et al.
Disease Models & Mechanisms|January 10, 2009
Disease modeling for Ebola and Marburg virusesDennis Bente, Jason Gren, James E Strong, et al.
International Journal of Radiation Biology|October 4, 2011
Modern dosimetric tools for (60)Co irradiation at high containment laboratoriesBarri Twardoski, Heinz Feldmann, Marshall E Bloom, et al.
Journal of Virology|June 14, 2003
Antibody-dependent enhancement of Ebola virus infectionAyato Takada, Heinz Feldmann, Thomas G Ksiazek, et al.
Antiviral Research|June 19, 2012
The Syrian hamster model of hantavirus pulmonary syndromeDavid Safronetz, Hideki Ebihara, Heinz Feldmann, et al.
The American Journal of Tropical Medicine and Hygiene|April 20, 2021
Inactivation of SARS-CoV-2 Laboratory SpecimensElaine Haddock, Friederike Feldmann, W Lesley Shupert, et al.
Journal of Bioterrorism & Biodefense|January 31, 2012
Vesicular Stomatitis Virus-Based Vaccines for Prophylaxis and Treatment of Filovirus InfectionsAndrea Marzi, Heinz Feldmann, Thomas W Geisbert, et al.
Journal of Virological Methods|June 25, 2003
Development, characterization and use of monoclonal VP40-antibodies for the detection of Ebola virusAndreas Lucht, Roland Grunow, Peggy Möller, et al.
Trends in Microbiology|September 24, 2004
Ebola virus ecology: a continuing mysteryHeinz Feldmann, Victoria Wahl-Jensen, Steven M Jones, et al.
Pageof 50

Showing results (61-70 of 495) with videos related to

Sort By:
Pageof 50
Plos Pathogens|September 16, 2021
The Ebola virus soluble glycoprotein contributes to viral pathogenesis by activating the MAP kinase signaling pathwayWakako Furuyama, Kyle Shifflett, Heinz Feldmann, et al.
Microorganisms|April 30, 2021
Lassa Virus Treatment OptionsFrederick Hansen, Michael A Jarvis, Heinz Feldmann, et al.
Disease Models & Mechanisms|January 10, 2009
Disease modeling for Ebola and Marburg virusesDennis Bente, Jason Gren, James E Strong, et al.
International Journal of Radiation Biology|October 4, 2011
Modern dosimetric tools for (60)Co irradiation at high containment laboratoriesBarri Twardoski, Heinz Feldmann, Marshall E Bloom, et al.
Journal of Virology|June 14, 2003
Antibody-dependent enhancement of Ebola virus infectionAyato Takada, Heinz Feldmann, Thomas G Ksiazek, et al.
Antiviral Research|June 19, 2012
The Syrian hamster model of hantavirus pulmonary syndromeDavid Safronetz, Hideki Ebihara, Heinz Feldmann, et al.
The American Journal of Tropical Medicine and Hygiene|April 20, 2021
Inactivation of SARS-CoV-2 Laboratory SpecimensElaine Haddock, Friederike Feldmann, W Lesley Shupert, et al.
Journal of Bioterrorism & Biodefense|January 31, 2012
Vesicular Stomatitis Virus-Based Vaccines for Prophylaxis and Treatment of Filovirus InfectionsAndrea Marzi, Heinz Feldmann, Thomas W Geisbert, et al.
Journal of Virological Methods|June 25, 2003
Development, characterization and use of monoclonal VP40-antibodies for the detection of Ebola virusAndreas Lucht, Roland Grunow, Peggy Möller, et al.
Trends in Microbiology|September 24, 2004
Ebola virus ecology: a continuing mysteryHeinz Feldmann, Victoria Wahl-Jensen, Steven M Jones, et al.
Pageof 50